See in this edition of Life Sciences & Healthcare Newsletter:
-
Anvisa opens inquiry for inputs regarding regulatory sandbox on cosmetics, hygiene products, and perfumes
-
Public Inquiry on new RDC regarding sanitary sanctioning administrative processes within Anvisa will remain open until early February
-
Anvisa publishes clarifications related to the import of medical device components
-
Anvisa publishes four new Public Inquiries on herbal medicines
-
MAPA establishes e-Phyto for the certification of plant origin products
-
ANPD and ANS sign cooperation agreement for information exchange and study development
-
Bioinputs Law sanctioned
-
Public Inquiry opened regarding sanitary risk management actions and reliance in CBPF and CBPD/A
-
Anvisa internalizes GMC MERCOSUL Resolution No. 18/2023 and updates concepts of personal hygiene products, cosmetics, and perfumes degree 1 and degree 2
-
Anvisa publishes regulation on electronic petitioning
-
New Anvisa RDC on the regulation of medicines came into effect on January 1, 2025
To check out the full content, please click here.
